Dr. Chiadi Onyike directs clinical and research programs at Johns Hopkins University that are focused on neurodegenerative disorders in young and middle-age adults. The research programs focus on the epidemiology, neuropsychiatry and clinical management of frontotemporal dementias, young-onset Alzheimer disease, spinocerebellar ataxias, Lewy body disease, prion diseases, and other neurodegenerative diseases. He is a principal investigator and co-investigator of NIH, foundation, industry and philanthropy sponsored research projects. He serves on the Medical Advisory Council of the Association for Frontotemporal Degeneration, on the Alzheimer's Association Best Clinical Practices Guidelines Work Group, the FTD Disorders Registry Scientific Advisory Board, the FDA Advisory Committee for Central and Peripheral Nervous System Drugs, and the Executive Committee of the International Society for Frontotemporal Dementias. Dr. Onyike received his Medical Degree from the University of Nigeria, and a graduate degree in Clinical Epidemiology from the Johns Hopkins Bloomberg School of Public Health. His training includes internships at the University of Nigeria Teaching Hospital and St. Elizabeth's/CMHS in Washington D.C., residency in Adult Psychiatry and fellowship in General Hospital Psychiatry (Johns Hopkins School of Medicine), and research fellowships in Neurochemistry/Cell Signaling (University of Maryland at Baltimore) and Psychiatric Epidemiology (Johns Hopkins Bloomberg School of Public Health).